首页 &/Job/JobDetail/x804C;&/Job/JobDetail/x4F4D;&/Job/JobDetail/x63CF;&/Job/JobDetail/x8FF0;

&/Job/JobDetail/x6297;&/Job/JobDetail/x4F53;&/Job/JobDetail/x5DE5;&/Job/JobDetail/x7A0B;&/Job/JobDetail/x52A9;&/Job/JobDetail/x7406;&/Job/JobDetail/x79D1;&/Job/JobDetail/x5B66;&/Job/JobDetail/x5BB6;/&/Job/JobDetail/x79D1;&/Job/JobDetail/x5B66;&/Job/JobDetail/x5BB6;

&/Job/JobDetail/x4E0A;&/Job/JobDetail/x6D77;&/Job/JobDetail/x5CB8;&/Job/JobDetail/x8FC8;&/Job/JobDetail/x751F;&/Job/JobDetail/x7269;&/Job/JobDetail/x79D1;&/Job/JobDetail/x6280;&/Job/JobDetail/x6709;&/Job/JobDetail/x9650;&/Job/JobDetail/x516C;&/Job/JobDetail/x53F8;

&/Job/JobDetail/x6D66;&/Job/JobDetail/x4E1C;&/Job/JobDetail/x65B0;&/Job/JobDetail/x533A;-&/Job/JobDetail/x5F20;&/Job/JobDetail/x6C5F;&/Job/JobDetail/x9547; | 1&/Job/JobDetail/x5E74;&/Job/JobDetail/x5DE5;&/Job/JobDetail/x4F5C;&/Job/JobDetail/x7ECF;&/Job/JobDetail/x9A8C; | &/Job/JobDetail/x672C;&/Job/JobDetail/x79D1;

2020-09-16发布

招聘人数:1&/Job/JobDetail/x4EBA;

15-20&/Job/JobDetail/x4E07;&/Job/JobDetail/x5143;/&/Job/JobDetail/x5E74;

申请职位

职位信息

职责概要: 候选人将支持抗体工程部门进行研究项目的抗体表达,噬菌体筛选等工作。 岗位职责: 1.抗体亲和力成熟等噬菌体文库的构建,筛选; 2.重组抗体及双特异性抗体的表达纯化,结合活性的鉴定和理化性质的分析; 3.整理数据并撰写实验报告; 4.与实验室日常运作和项目相关的其他工作。 任职资格: 1.分子生物学、生物化学或相关专业硕士及以上学历; 2.至少3年以上相关领域工作或科研经验;熟练掌握分子克隆相关实验技能; 3.具有双特异性抗体相关经验的优先; 4.有较好的口头、书面表达能力,良好的英文阅读和书写能力; 5.有团队合作精神、责任心、较强的学习适应能力、较强的独立分析和解决问题的能力。

联系方式

上班地址:金科路4560号2号楼6楼

&/Job/JobDetail/x4E0A;&/Job/JobDetail/x6D77;&/Job/JobDetail/x5CB8;&/Job/JobDetail/x8FC8;&/Job/JobDetail/x751F;&/Job/JobDetail/x7269;&/Job/JobDetail/x79D1;&/Job/JobDetail/x6280;&/Job/JobDetail/x6709;&/Job/JobDetail/x9650;&/Job/JobDetail/x516C;&/Job/JobDetail/x53F8;


?&/Job/JobDetail/x5916;&/Job/JobDetail/x8D44;&/Job/JobDetail/xFF08;&/Job/JobDetail/x975E;&/Job/JobDetail/x6B27;&/Job/JobDetail/x7F8E;&/Job/JobDetail/xFF09;

? 50-150&/Job/JobDetail/x4EBA;

? &/Job/JobDetail/x5236;&/Job/JobDetail/x836F;/&/Job/JobDetail/x751F;&/Job/JobDetail/x7269;&/Job/JobDetail/x5DE5;&/Job/JobDetail/x7A0B;

上海岸迈生物科技有限公司是位于上海浦东新区张江高科技园区的一家新兴的创新型国际化生物技术企业,专注于利用自主知识产权的双特异性抗体技术平台(FIT-Ig)进行创新生物药的研究和开发。FIT-Ig技术是一项新型的双特异性抗体的技术平台,该技术平台能够通过简单的分子生物学手段将两个抗体串联在一起形成双抗,该双抗同时具备了两个原始抗体的功能,拥有双重活性和产业化优势。基于FIT-Ig平台技术,岸迈生物目前拥有十几个自主开发的 First-in-class 生物大分子新药研发项目,专注于恶性肿瘤靶向治疗,肿瘤免疫,T细胞导向治疗等领域。FIT-Ig技术同时也吸引了国内外多个主流生物医药企业的关注,目前已经和包括信达生物、英国Kymab公司等在内的多家企业达成了技术与产品的合作,岸迈将通过技术授权、合作开发、共享收益等多种形式实现平台战略发展,为国内药企开发双抗药物起到了引领示范和带头作用。20179月,岸迈生物荣获2017年中国创新创业大赛(生物医药行业初创组)全国总决赛冠军。
查看该公司所有职位